Neuren - where to from here ?, page-55

Hotcopper tends to destroy your formatting when you post. Have tried to repost the tables I included below in a more readable format.

Hashan's POS from Table 4 of his article

	Phelan-McDermid:	Phase III	30%
1	Angelman:	Phase II	15%
2	Pitt-Hopkins:	Phase II	15%
3	Prader-Willi:	Phase II	10%

Comparing patient numbers from Hashan vs Neuren.

		Hashan	Neuren
1	Phelan-McDermid	40k	24k
2	Angelman	27k	19k
3	Pitt-Hopkins	29k	6k
4	Prader-Willi	32k	17k

Comparing POS from Hashan vs published research.

		Phase	Table 4	90-95% disc	Wong et al (2019) MIT
1	Phelan-McDermid	Phase III	30%	5%-10%	32%
2	Angelman	Phase II	15%	5%-10%	8.3%
3	Pitt-Hopkins	Phase II	15%	5%-10%	8.3%
4	Prader-Willi	Phase II	10%	5%-10%	8.3%